When this happens, a type of white blood cell called B cells become activated and produce Anti-Drug Antibodies or ADAs. These antibodies bind to the biologics and reduce or completely deactivate ...

A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...

Ideally, anti-cancer treatments should specifically ... Building on these advances, antibody drug conjugate (ADC) therapy has emerged with worldwide marketing approvals for the indications of ...

In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

The researchers found that when the anti-cancer antibody binds to P-cadherin, it locks it into the X-dimer form. The stable X-form then triggers a chemical signal that causes that patch of membrane to ...

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug ...

("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National ...

25 (Xinhua) -- A Chinese research team has isolated an antibody from alpacas that can effectively inhibit HIV, providing a promising avenue for the development of new anti-AIDS drugs. The findings ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...